Home Cart 0 Sign in  

[ CAS No. 149709-62-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 149709-62-6
Chemical Structure| 149709-62-6
Structure of 149709-62-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 149709-62-6 ]

Related Doc. of [ 149709-62-6 ]

Alternatived Products of [ 149709-62-6 ]

Product Details of [ 149709-62-6 ]

CAS No. :149709-62-6 MDL No. :MFCD00920862
Formula : C24H29NO5 Boiling Point : -
Linear Structure Formula :- InChI Key :PYNXFZCZUAOOQC-UTKZUKDTSA-N
M.W : 411.49 Pubchem ID :9811834
Synonyms :
AHU-377

Calculated chemistry of [ 149709-62-6 ]

Physicochemical Properties

Num. heavy atoms : 30
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.38
Num. rotatable bonds : 13
Num. H-bond acceptors : 5.0
Num. H-bond donors : 2.0
Molar Refractivity : 115.78
TPSA : 92.7 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.15 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.88
Log Po/w (XLOGP3) : 3.74
Log Po/w (WLOGP) : 3.84
Log Po/w (MLOGP) : 3.15
Log Po/w (SILICOS-IT) : 4.73
Consensus Log Po/w : 3.67

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 1.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -4.19
Solubility : 0.0268 mg/ml ; 0.0000652 mol/l
Class : Moderately soluble
Log S (Ali) : -5.38
Solubility : 0.00172 mg/ml ; 0.00000418 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -6.79
Solubility : 0.0000675 mg/ml ; 0.000000164 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 3.61

Safety of [ 149709-62-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 149709-62-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 149709-62-6 ]
  • Downstream synthetic route of [ 149709-62-6 ]

[ 149709-62-6 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 149709-62-6 ]
  • [ 137862-53-4 ]
  • [ 936623-90-4 ]
YieldReaction ConditionsOperation in experiment
44.1 g With sodium hydroxide In water; acetone at 25℃; Sacubitril (19.0 g, 46.2 mmol) and Valsartan (19.5 g, 44.8 mmol) were dissolved in acetone (1900 mL) under magnetic stirring at 25 °C. A solution of sodium hydroxide (5.3 g, 132.2 mmol) in water (333 mL) was added to the former solution maintaining the resulting mixture under stirring up to obtaining a clear solution (pH = 9.44). The solution was evaporated at 35 °C for 9 hours under reduced pressure (between about 15 and 25 mbar) to yield 44.1 g of a glassy solid characterized by an XRPD spectrum compatible with an amorphous powder and having a water content of 5.7percent by weight.
Reference: [1] Patent: WO2017/12917, 2017, A1, . Location in patent: Page/Page column 15
Same Skeleton Products
Historical Records

Similar Product of
[ 149709-62-6 ]

Chemical Structure| 1369773-39-6

A120485[ 1369773-39-6 ]

Calcium 4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate

Reason: Free-salt